AU2001267887A1 - Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components - Google Patents

Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Info

Publication number
AU2001267887A1
AU2001267887A1 AU2001267887A AU2001267887A AU2001267887A1 AU 2001267887 A1 AU2001267887 A1 AU 2001267887A1 AU 2001267887 A AU2001267887 A AU 2001267887A AU 2001267887 A AU2001267887 A AU 2001267887A AU 2001267887 A1 AU2001267887 A1 AU 2001267887A1
Authority
AU
Australia
Prior art keywords
components
medicinal
parathyroid hormone
nasal administration
administration containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001267887A
Other versions
AU2001267887B2 (en
Inventor
Kouji Kawanishi
Yoshiharu Minamitake
Tetsu Ono
Yuji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd
Priority claimed from PCT/JP2001/005674 external-priority patent/WO2002002136A1/en
Publication of AU2001267887A1 publication Critical patent/AU2001267887A1/en
Assigned to DAIICHI SUNTORY PHARMA CO LTD reassignment DAIICHI SUNTORY PHARMA CO LTD Request for Assignment Assignors: SUNTORY LIMITED
Assigned to DAIICHI SUNTORY PHARMA CO., LTD. reassignment DAIICHI SUNTORY PHARMA CO., LTD. Amend patent request/document other than specification (104) Assignors: DAIICHI SUNTORY PHARMA CO LTD
Assigned to DAIICHI ASUBIO PHARMA CO., LTD reassignment DAIICHI ASUBIO PHARMA CO., LTD Request for Assignment Assignors: DAIICHI SUNTORY PHARMA CO., LTD.
Application granted granted Critical
Publication of AU2001267887B2 publication Critical patent/AU2001267887B2/en
Assigned to ASUBIO PHARMA CO., LTD reassignment ASUBIO PHARMA CO., LTD Request for Assignment Assignors: DAIICHI ASUBIO PHARMA CO., LTD
Assigned to ASUBIO PHARMA CO., LTD. reassignment ASUBIO PHARMA CO., LTD. Request for Assignment Assignors: ASUBIO PHARMA CO., LTD
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001267887A 2000-06-30 2001-06-29 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components Ceased AU2001267887B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000237717 2000-06-30
JP2000-237718 2000-06-30
JP2000237718 2000-06-30
JP2000-237717 2000-06-30
PCT/JP2001/005674 WO2002002136A1 (en) 2000-06-30 2001-06-29 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Publications (2)

Publication Number Publication Date
AU2001267887A1 true AU2001267887A1 (en) 2002-04-11
AU2001267887B2 AU2001267887B2 (en) 2007-02-15

Family

ID=26597441

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6788701A Pending AU6788701A (en) 2000-06-30 2001-06-29 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
AU2001267887A Ceased AU2001267887B2 (en) 2000-06-30 2001-06-29 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU6788701A Pending AU6788701A (en) 2000-06-30 2001-06-29 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components

Country Status (16)

Country Link
US (1) US7087248B2 (en)
EP (1) EP1297842A4 (en)
KR (1) KR20030016315A (en)
CN (1) CN100518819C (en)
AR (1) AR032461A1 (en)
AU (2) AU6788701A (en)
BR (1) BR0112381A (en)
CA (1) CA2414966A1 (en)
IL (1) IL153678A0 (en)
MX (1) MXPA02012947A (en)
MY (1) MY136546A (en)
NO (1) NO325831B1 (en)
NZ (1) NZ523457A (en)
RU (1) RU2292219C2 (en)
TW (1) TWI293563B (en)
WO (1) WO2002002136A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075913A1 (en) 2003-02-28 2004-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilized preparation containing protein
AU2005260834A1 (en) * 2004-07-14 2006-01-19 Chugai Seiyaku Kabushiki Kaisha PTH-containing preparation for transmucosal administration
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
KR200449313Y1 (en) * 2008-02-18 2010-06-30 손복만 The agriculture waterway having the drain valve
JP2011001317A (en) * 2009-06-19 2011-01-06 Fumakilla Ltd Cleaning agent for nose
ES2663322T3 (en) 2009-09-09 2018-04-12 Asahi Kasei Pharma Corporation Therapeutic / prophylactic agent containing PTH for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 200 units
KR101686271B1 (en) 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2471554A1 (en) 2010-12-28 2012-07-04 Hexal AG Pharmaceutical formulation comprising a biopharmaceutical drug
WO2012169435A1 (en) 2011-06-07 2012-12-13 旭化成ファーマ株式会社 Freeze-dried preparation containing high-purity pth and method for producing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
JP2505812B2 (en) 1987-07-10 1996-06-12 旭化成工業株式会社 Freeze-dried composition of h-PTH (1-34)
GB9020544D0 (en) 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5208041A (en) * 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
JPH05271279A (en) * 1991-08-07 1993-10-19 Takeda Chem Ind Ltd Human parathyroid hormone mutein and its production
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
DE19538687A1 (en) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stable pharmaceutical dosage forms containing parathyroid hormone

Similar Documents

Publication Publication Date Title
SI1385494T1 (en) Compositions containing formoterol and a steroid for delivery into the lungs
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
IL145983A0 (en) Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof
HUP0104574A3 (en) Analogues of glp-1, pharmaceutical compositions comprising thereof and their use
HUP0104579A3 (en) Glp-1 analogues, pharmaceutical compositions comprising thereof and their use
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
SI1329456T1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL152024A0 (en) Pharmaceutical compositions containing thyroid hormone and processes for the manufacture thereof
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL155088A0 (en) Medicinal aerosol formulations
HUP0202862A3 (en) Pharmaceutical composition containing novel combination of loteprednol and antihistamines
MXPA02001631A (en) Pharmaceutical compositions for oral and topical administration.
AU2001267887A1 (en) Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
AU6788701A (en) Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
HUP0400120A3 (en) Pharmaceutical composition for orally administering parathyroid hormone and calcitonin
AU2001258550A1 (en) Insulin formulation for inhalation
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof
AU2001274236A1 (en) Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist
GB0201607D0 (en) Formulation for the administration of medicinal substances
HUP0400440A2 (en) Pharmaceutical composition for nasal delivery of estradiol and norethisterone
AU2002336141A1 (en) Pharmaceutical composition for nasal delivery of estradiol and norethisterone
AU2001287930A1 (en) Pharmaceutical formulation for pulmonary or nasal administration
AU2001284287A1 (en) Pharmaceutical combination containing salmeterol and fluticasone
AU6633101A (en) Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient